Skip to content

MUSIMEDIC

Inactive KBO/BCE: BE 0480.197.213
MUSIMEDIC
Financial year 2016
Follow Report

Annual accounts 2016

micro format, filed on 20-05-2017, 72 days before the deadline
Gross margin
€43,015
▲ 376%
Operating result
-€45,326
▲ €527
Loss
-€56,628
▲ €10,689
Working capital
-€223,576
▼ €125,027
Solvency
-82.7%
▼ 52.0 percentage points
Current ratio
0.09
▼ 0.30

The turnover shown is an estimate from the gross margin.

Turnover ≈ €170,000. Estimated: probably between €100,000 and €310,000.

Balance sheet

balance sheet total €140,161 on 31-12-2016
What the company ownsHow it is paid for

Change in equityin euro

Change in cashin euro

Staff

Staff cost per FTE€30,240

Staff costs divided by the average number of full-time equivalents.

Joined and left

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend20162015201420132012201120102009200820072006
Balance sheet: assets
Total assets20/58 140,161192,920175,336249,882293,122304,143283,472287,890290,829143,626128,860
Fixed assets21/28 117,168129,816133,096187,983210,490197,449210,433229,844226,09454,16135,945
Intangible fixed assets21 -3,754---------
Tangible fixed assets22/27 117,168126,062133,096187,483210,490197,449210,433229,844226,09454,16135,945
Land and buildings22 117,168122,643128,119133,862139,381144,901150,421150,574155,873--
Plant, machinery and equipment23 03,4184,97830,45639,46333,36633,54944,53448,67232,3067,963
Furniture and vehicles24 ---18,76125,09811,24016,45222,6567,4001,236894
Other tangible fixed assets26 ---4,4046,5487,94210,01112,08014,14916,21918,288
Financial fixed assets28 ---500-------
Current assets29/58 22,99263,10442,24061,89982,632106,69473,03958,04664,73589,46592,915
Stocks and contracts in progress3 15,57429,25925,20129,31631,05828,37221,04225,37514,7435,937632
Stocks30/36 15,57429,25925,20129,31631,05828,37221,04225,37514,7435,937632
Amounts receivable within one year40/41 4,97733,15413,94217,17724,67335,5467,39516,86320,99529,97129,729
Trade receivables40 4,9776,7869,77015,94116,98628,1116,32415,42813,6149,50811,597
Other amounts receivable41 -26,3674,1721,2367,6877,4351,0711,4357,38120,46318,132
Current investments50/53 ---------20,000-
Cash at bank and in hand54/58 2,4412249698,13023,77936,67641,13711,39725,94929,59162,384
Deferred charges and accrued income490/1 -4672,1287,2763,1226,1003,4654,4113,0483,966170
Balance sheet: equity and liabilities
Total equity and liabilities10/49 140,161192,920175,336249,882293,122304,143283,472287,890290,829143,626128,860
Equity10/15 -115,907-59,2808,03747,89963,37485,65878,31342,89142,96189,32097,231
Contributions10/11 18,25018,25018,25012,2506,2506,2506,2506,2506,2506,2506,250
Issued capital100 18,60018,60018,60018,60018,60018,60018,60018,60018,60018,60018,600
Uncalled capital101 3503503506,35012,35012,35012,35012,35012,35012,35012,350
Reserves13 1,8601,8601,8601,8601,8601,8601,8601,8601,8601,8601,860
Legal reserve130 1,8601,8601,8601,8601,8601,8601,8601,8601,8601,8601,860
Profit (loss) carried forward14 -136,017-79,390-12,07333,78955,26477,54870,20334,78134,85181,21089,121
Provisions and deferred taxes16 9,500----------
Deferred taxes168 9,500----------
Amounts payable17/49 246,568252,200167,299201,983229,748218,485205,159244,999247,86854,30631,629
Amounts payable after more than one year17 -90,54770,504103,858139,048133,725152,829180,818188,46116,3296,847
Financial debts170/4 -90,54770,504103,858139,048133,725152,829180,818188,46116,3296,847
Amounts payable within one year42/48 246,568161,65496,41398,12590,70084,76052,33064,18159,40737,97724,782
Current portion of amounts payable after more than one year42 90,5479,01033,61535,19037,56928,28827,98827,12822,67518,37913,557
Financial debts43 51,03353,0348,2326,142-------
Credit institutions430/8 51,03353,0348,2326,142-------
Trade debts44 29,14644,77945,88638,28434,82531,69016,50726,97028,42513,9566,156
Suppliers440/4 29,14644,77945,88638,28434,82531,69016,50726,97028,42513,9566,156
Advances received on contracts in progress46 ---2,9501,0894,1141,25631100--
Taxes, remuneration and social security45 32,78914,6905,38914,9309,56115,3093,5218,6238,2075,6425,069
Taxes450/3 10,6544,48911411-4,244250819---
Remuneration and social security454/9 22,13410,2015,27514,9199,56111,0653,2717,8048,2075,6425,069
Other amounts payable47/48 43,05440,1413,2916297,6565,3593,0581,429---
Accrued charges and deferred income492/3 --382--------
Income statement
Non-recurring operating income76A --1242,6815,3129,04327,3775,0041,7462,612161
Gross operating margin9900 43,0159,04136,48686,58783,943105,04091,54270,56740,73958,35286,736
Remuneration, social security and pensions62 30,24045,75464,07974,64565,60263,09744,45036,72345,43642,43135,269
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 19,6697,0347,18524,47634,74926,79924,77826,42333,26015,25415,850
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4 15,574--123-91----1,081
Other operating charges640/8 1,9442,1053,6813,0322,8073,7913,1952,0553,9964,151119
Non-recurring operating charges66A 20,91512,40375190274100491-10095210
Operating profit (loss)9901 -45,326-45,852-38,459-15,689-19,21511,26219,1195,366-41,953-3,48434,417
Financial income75/76B 11,158956781,4147142416692,1071,7371,370
Recurring financial income75 11,158956781,4147142416692,1071,7371,370
Financial charges65/66B 11,41510,1457,4109,0319,2789,56810,59811,3548,8441,7072,042
Recurring financial charges65 11,41510,1457,4109,0319,2789,56810,59811,3548,8441,7072,042
Profit (loss) for the period before taxes9903 -56,739-67,242-45,725-21,551-22,04111,35135,648-315-47,044-93733,696
Income taxes67/77 -11275117-762434,006226-245-6856,9747,546
Profit (loss) for the period9904 -56,628-67,317-45,843-21,475-22,2847,34535,422-70-46,359-7,91126,150
Profit (loss) for the period to be appropriated9905 -56,628-67,317-45,843-21,475-22,2847,34535,422-70-46,359-7,91126,150
Appropriation of the result
Profit (loss) to be appropriated9906 -136,017-79,390-12,07333,78955,26477,54870,20334,78134,85181,21089,121
Social balance sheet
Average staff (FTE)9087 1321.51.71.71.51.61.111
Hours worked1013 1,7203,6902,9562,6442,2582,6612,0782,2002,0431,7731,830
Document PDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDF

The accounts for 2 older financial years (2004-2005) were filed as documents without figures as data, scans for example.

Source: Annual accounts 2016 (PDF), filed on 20-05-2017.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2016 micro format 20-05-2017 2017-13000325 PDF
31-12-2015 full format 09-06-2016 2016-17500132 PDF
31-12-2014 full format 30-08-2015 2015-56800591 PDF
31-12-2013 full format 19-08-2014 2014-44000079 PDF
31-12-2012 full format 13-08-2013 2013-42100245 PDF
31-12-2011 full format 20-08-2012 2012-43900592 PDF
31-12-2010 full format 12-08-2011 2011-41000387 PDF
31-12-2009 full format 14-06-2010 2010-19100336 PDF
31-12-2008 full format 31-07-2009 2009-52400378 PDF
31-12-2007 full format 05-08-2008 2008-54000310 PDF
31-12-2006 full format 20-08-2007 2007-58300193 PDF
31-12-2005 full format 25-08-2006 2006-67701497 PDF
31-12-2004 full format 22-09-2005 2005-70100898 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend20162015201420132012201120102009200820072006
EBITDA -25,657-38,818-31,2748,78715,53438,06143,89731,789-8,69311,77050,267
Cash flow -36,959-60,283-38,6573,00112,46534,14460,20026,353-13,0997,34342,000
Investment in fixed assets (approximation) 7,0213,754-47,7021,96956,37514,0635,71830,173205,19333,47025,339
Change in cash 2,217-744-7,161-15,649-12,897-4,46129,740-14,552-3,642-32,793-
Working capital -223,576-98,549-54,173-36,226-8,06821,93420,709-6,1355,32851,48868,133
Solvency -82.7%-30.7%4.6%19.2%21.6%28.2%27.6%14.9%14.8%62.2%75.5%
Current ratio 0.090.390.440.630.911.261.400.901.092.363.75
Quick ratio 0.030.210.180.330.570.920.990.510.842.203.72
Debt to equity --20.824.223.632.552.625.715.770.610.33
ROE ---570.4%-44.8%-35.2%8.6%45.2%-0.2%-107.9%-8.9%26.9%
ROA -40.4%-34.9%-26.1%-8.6%-7.6%2.4%12.5%0.0%-15.9%-5.5%20.3%

EBIT margin: not included in this filing.

Debt to equity is not shown because equity is negative. Debt divided by negative equity means nothing.

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Insights on MUSIMEDIC

The operating result for 2016 is a loss of €45,326, smaller than the loss of €45,852 in 2015.

Equity is negative. Debt (€246,568) exceeds the balance-sheet total (€140,161).

We would like to set cookies. That happens only with your consent. What we measure